NCT00611520已完成不适用
Symbicort in Chronic Obstructive Pulmonary Disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 64,730
研究概览
简要总结
Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. pneumologists and internists) are asked to document relevant data related to the budesonide/formoterole therapy in patients with COPD.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with COPD treated with budesonide/formoterol
排除标准
- •limitations; possible risks; warnings; contraindications mentioned in the SPC.
研究者
相似试验
已完成
不适用
Symbicort in Chronic Obstruktive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveNCT00612976AstraZeneca18,014
招募中
不适用
Electronic Snapshot for Outpatient Management of Chronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseasePublic Health - Health service researchACTRN12614000296639The Prince Charles Hospital200
招募中
不适用
Evaluation of chronic obstructive pulmonary disease (COPD) and association between COPD severity and cardiac function at MRI.chronic obstructive pulmonary diseaseJPRN-UMIN000013230Asahikawa Medical University20
已完成
不适用
Effect of Self-directed and Supervised Pulmonary Rehabilitation Approach on Cough and Sputum.COPDPulmonary DiseaseNCT05538975Afridi Medical Complex40
已完成
2 期
The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary DiseaseNCT00939211AstraZeneca25